EXTERNAL QUALITY ASSESSMENT


when oxygenating in room air; with values < 8.0 kPa (< 60 mmHg) indicating respiratory failure.


Although blood gas analysers have been developed and refined over recent decades, the technology used to measure pO2


remains largely similar


to that used in the earliest instruments. The Clark oxygen sensor, introduced in 1958, relies on reduction of oxygen to hydroxy ions to generate an electrical current, via a silver/silver chloride and platinum electrode system.3


As oxygen


present in blood diffuses across an oxygen-permeable membrane and into the electrode, the current changes proportionally to the concentration of oxygen in the sample, providing an assessment of pO2


in blood.


Fig 1. The oxyhaemoglobin dissociation curve models the relationship between pO2 oxygen saturation. At normal arterial pO2, small changes in pO2 haemoglobin and hence delivery to the tissues, but as pO2 considerably impaired, with pO2 <8 kPa indicating respiratory failure.


by non-laboratory personnel. The clinical impact of POCT blood gas analysers is significant: reducing time to treatment in acute medicine, leading to improvement in patient outcomes and reducing workload for central laboratories. However, maintaining competency of users, managing cost of consumables, and standardisation of different devices remains a challenge for pathology services.


The first clinical question asked as part of interpretation of ABG is whether the patient is hypoxic, requiring supplemental oxygen, as this is the most immediate threat to life.2


The


oxygenation status of the patient is assessed by pO2


. This parameter


measures the amount of oxygen dissolved in the patient’s blood, which is not bound to haemoglobin. Oxygen is poorly soluble in blood, and > 98 % of the total oxygen content of the blood is bound to haemoglobin – forming oxyhaemoglobin. There are


and haemoglobin have little effect on saturation of falls below 10 kPa, oxygen delivery becomes


several factors determining whether oxygen is bound to haemoglobin, including pO2


. When pO2 is high,


such as in the alveolar blood vessels, haemoglobin has a much higher affinity for oxygen and forms oxyhaemoglobin. When pO2


is reduced, such as in


is lower, such as in peripheral tissues, haemoglobin affinity for oxygen decreases, and oxygen is released into the blood and diffuses into the tissues. If pO2


asthma, pneumonia or other lung diseases, less oxygen can be carried by haemoglobin, and less oxygen is delivered to the tissues. According to the oxygen dissociation curve which


models the relationship between pO2 and haemoglobin oxygen saturation, small changes in pO2


on saturation of haemoglobin and hence delivery to the tissues, but as pO2


typically 10-13 kPa (75-100 mmHg) have little effect


falls below 10 kPa, oxygen delivery becomes considerably impaired (Fig 1). In a healthy patient, arterial pO2


is


Modern blood gas analysers feature improvements over the original design, such as miniaturisation of components, improved membrane composition, allowing for better accuracy and response time, automated temperature controls and better calibration processes. Some manufacturers have moved away from the Clark electrode and have incorporated optical sensors for measuring pO2


into instruments.4 Optical


sensors comprise a luminescent dye embedded in a matrix, which emits light with intensity inversely proportional to the concentration of oxygen in the sample. Although their use is currently limited in clinical practice, these devices require a reduced level of calibration and maintenance and have longer lifespan than the Clark electrode; and may be particularly applicable to continuous monitoring devices.


External quality assessment As with all laboratory analysers and point-of-care instruments, external quality assessment (EQA) is essential to ensure that blood gas analysers provide accurate results that are appropriate for patient care. Since April 1995, Weqas has distributed three EQA samples monthly for blood gas analysers at both laboratory and POCT testing sites, covering H+ , electrolytes, glucose and


, pCO2 , pO2


The clinical impact of POCT blood gas analysers is significant. However, maintaining competency of users, managing cost of consumables, and standardisation of different devices remains a challenge for pathology services


38


lactate; and since 2008, urea and creatinine. Tonometry with predetermined levels of oxygen and carbon dioxide balanced with nitrogen and different salt concentrations provide six distinct levels for each parameter, simulating clinically significant ranges of acid-base and electrolyte balance, respiratory function, renal function, glucose, and lactate concentration. The standard aqueous material includes the addition of protein which minimises the risk of preanalytical sampling error through exposure to room air, by forming a protein foam layer. The


SEPTEMBER 2025 WWW.PATHOLOGYINPRACTICE.COM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84